Healthcare provider profile · identity verified

David A Mesker, MD

Family Practice · ENGLEWOOD, OH · NPI 1093793762

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Omeprazole	Omeprazole	560	144
Rosuvastatin Calcium	Rosuvastatin Calcium	548	128
Levothyroxine Sodium	Levothyroxine Sodium	541	140
Lisinopril	Lisinopril	518	130
Atorvastatin Calcium	Atorvastatin Calcium	482	138
Amlodipine Besylate	Amlodipine Besylate	318	75
Gabapentin	Gabapentin	260	60
Furosemide	Furosemide	243	56
Metformin Hcl	Metformin Hcl	221	66
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	218	44
Pravastatin Sodium	Pravastatin Sodium	211	56
Alendronate Sodium	Alendronate Sodium	203	54
Montelukast Sodium	Montelukast Sodium	194	49
Losartan Potassium	Losartan Potassium	190	48
Metoprolol Tartrate	Metoprolol Tartrate	170	43
Hydrochlorothiazide	Hydrochlorothiazide	157	46
Pantoprazole Sodium	Pantoprazole Sodium	157	44
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	154	44
Trazodone Hcl	Trazodone Hcl	149	31
Albuterol Sulfate Hfa	Albuterol Sulfate	147	41
Tamsulosin Hcl	Tamsulosin Hcl	143	43
Sertraline Hcl	Sertraline Hcl	141	31
Glimepiride	Glimepiride	140	41
Simvastatin	Simvastatin	139	36
Diclofenac Sodium	Diclofenac Sodium	133	35
Celecoxib	Celecoxib	130	33
Lorazepam	Lorazepam	121	23
Potassium Chloride	Potassium Chloride	118	27
Citalopram Hbr	Citalopram Hydrobromide	116	25
Fenofibrate	Fenofibrate	116	25
Pioglitazone Hcl	Pioglitazone Hcl	107	31
Synthroid	Levothyroxine Sodium	102	28
Clopidogrel	Clopidogrel Bisulfate	101	26
Zolpidem Tartrate	Zolpidem Tartrate	96	21
Metoprolol Succinate	Metoprolol Succinate	95	28
Famotidine	Famotidine	88	30
Januvia	Sitagliptin Phosphate	86	22
Ozempic	Semaglutide	85	12
Alprazolam	Alprazolam	84	15
Clonazepam	Clonazepam	83	15
Escitalopram Oxalate	Escitalopram Oxalate	81	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	77	16
Jardiance	Empagliflozin	74	20
Allopurinol	Allopurinol	73	21
Tramadol Hcl	Tramadol Hcl	72	15
Ibuprofen	Ibuprofen	71	18
Eliquis	Apixaban	70	13
Fluticasone Propionate	Fluticasone Propionate	70	26
Paroxetine Hcl	Paroxetine Hcl	70	16
Bupropion Xl	Bupropion Hcl	69	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	20
Ezetimibe	Ezetimibe	68	22
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	67	17
Esomeprazole Magnesium	Esomeprazole Magnesium	65	11
Mounjaro	Tirzepatide	62	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	16
Methocarbamol	Methocarbamol	57	15
Aripiprazole	Aripiprazole	53	suppressed
Buspirone Hcl	Buspirone Hcl	53	11
Doxepin Hcl	Doxepin Hcl	53	suppressed
Duloxetine Hcl	Duloxetine Hcl	53	14
Risperidone	Risperidone	45	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	12
Warfarin Sodium	Warfarin Sodium	44	suppressed
Naproxen	Naproxen	43	suppressed
Pregabalin	Pregabalin	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Baclofen	Baclofen	40	suppressed
Carvedilol	Carvedilol	40	12
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	26
Prednisone	Prednisone	38	22
Ropinirole Hcl	Ropinirole Hcl	38	suppressed
Lovastatin	Lovastatin	37	11
Mirtazapine	Mirtazapine	37	12
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Clonidine Hcl	Clonidine Hcl	35	suppressed
Xarelto	Rivaroxaban	33	suppressed
Finasteride	Finasteride	32	13
Diazepam	Diazepam	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	suppressed
Methylprednisolone	Methylprednisolone	30	24
Advair Hfa	Fluticasone Propion/Salmeterol	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Glipizide	Glipizide	27	suppressed
Meclizine Hcl	Meclizine Hcl	27	14
Meloxicam	Meloxicam	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Rizatriptan	Rizatriptan Benzoate	26	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	26	20
Tizanidine Hcl	Tizanidine Hcl	26	13
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	25	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	25	suppressed
Sucralfate	Sucralfate	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Breo Ellipta	Fluticasone/Vilanterol	23	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	23	suppressed
Benazepril Hcl	Benazepril Hcl	22	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Atenolol	Atenolol	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Clobetasol Propionate	Clobetasol Propionate	20	11
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Brilinta	Ticagrelor	19	suppressed
Eszopiclone	Eszopiclone	19	suppressed
Metformin Hcl Er	Metformin Hcl	19	suppressed
Spiriva Respimat	Tiotropium Bromide	19	suppressed
Topiramate	Topiramate	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Nystatin	Nystatin	18	11
Promethazine Hcl	Promethazine Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Carisoprodol	Carisoprodol	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Klor-Con M10	Potassium Chloride	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Aliskiren	Aliskiren Hemifumarate	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Ramipril	Ramipril	15	suppressed
Klor-Con M20	Potassium Chloride	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Testosterone Cypionate	Testosterone Cypionate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Calcitriol	Calcitriol	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Flunisolide	Flunisolide	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Repatha Syringe	Evolocumab	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Butorphanol Tartrate	Butorphanol Tartrate	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Dexamethasone	Dexamethasone	11	suppressed
Leucovorin Calcium	Leucovorin Calcium	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed
Morphine Sulfate	Morphine Sulfate	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error